| Cat.No. | Name | Information |
|---|---|---|
| M45250 | DCSZ11 | DCSZ11 is a monoclonal antibody targeting CD93 for studies related to solid tumors. |
| M45249 | DCBY02 | DCBY02 is a monoclonal antibody targeting CD93 for studies related to solid tumors. |
| M45225 | NPX887 | NPX887 is a monoclonal antibody targeting the co-stimulatory molecule B7H7, which can be used in studies related to solid tumors. |
| M45224 | BI-1910 | BI-1910 is a monoclonal antibody targeting anti-tumor necrosis factor receptor 2 (TNFR2). |
| M45223 | Casdozokitug | Casdozokitug is an IgG1κ antibody targeting IL27. |
| M45222 | TEV’574 | TEV'574 is a TL1A antibody with a unique binding epitope that blocks TL1A binding to the DR3 receptor without affecting TL1A binding to the DcR3 pseudoreceptor. It can be used in studies related to ulcerative colitis and Crohn's disease. |
| M45221 | TEV-48574 | TEV-48574 is a TL1A-targeted monoclonal antibody that can be used in studies related to ulcerative colitis (UC). |
| M45160 | LY3499446 | LY3499446 is a KRAS G12C covalent inhibitor for studies related to non-small cell lung cancer (NSCLC). |
| M45157 | OS2966 | OS2966 is a first-in-class (first-in-class) neutralizing anti-CD29 monoclonal antibody that selectively modulates CD29 (integrin b1 subunit) and can be used in glioblastoma-related studies. |
| M45134 | IMVT-1402 | IMVT-1402 is a potential best-in-class (BIC) neonatal Fc receptor (FcRn)-targeting antibody for studies related to autoimmune diseases. |
| M45115 | PMN310 | PMN310 is a beta-amyloid oligomer (AβO) antibody that can be used in studies related to Alzheimer's disease (AD). |
| M43951 | MK-2060 | MK-2060 is a monoclonal antibody with dual activity to inhibit coagulation factors XI and Xia, blocking both the activation of coagulation factor XI and the downstream activity of the activated protein. It can be used in studies related to end-stage renal disease (ESRD). |
| M43950 | Xisomab 3G3 | Xisomab 3G3 is a recombinant human-derived monoclonal antibody to coagulation factor XI (F11) that blocks factor XI activation mediated by factor XIIa in a concentration-dependent manner. |
| M43942 | AMG-820 | AMG-820 is an anti-colony stimulating factor 1 receptor (CSF1R) monoclonal antibody. |
| M43929 | Zigakibart | Zigakibart is an anti-APRIL monoclonal antibody that can be used in studies related to IgA nephropathy (IgAN). |
| M40986 | NGM-313 | NGM-313 is a β-Klotho/FGFR1c-targeted monoclonal antibody for studies related to non-alcoholic steatohepatitis (NASH). |
| M40938 | Rat IgG2a Isotype Control In vivo | Rat IgG2a Isotype Control In vivo can be used as an isotype-matched control for rat IgG2a antibodies. |
| M40937 | Suciraslimab | Suciraslimab is a potentially first-in-class monoclonal antibody against the B-cell target CD22, which can help change CD22 from cis-binding to trans-binding and form a stable CD22 trans-binding structure, thereby restoring B-cell tolerance to its own antigens and inhibiting B-cells from undergoing a series of related immune responses to attack its own organism. |
| M40905 | Remternetug | Remternetug is an IgG1 monoclonal antibody that targets the pyroglutamate modification of the third amino acid of the amyloid beta peptide present only in brain amyloid plaques, and can be used in studies related to Alzheimer's disease (AD). |
| M40876 | Ebdarokimab | Ebdarokimab is a monoclonal antibody to IL-12p40/IL-23 that can be used in studies related to inflammatory bowel disease (IBD). |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
